How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the andalusian heart failure registry (RAIC) study;¿Cuántos pacientes ingresados por insuficiencia cardiaca son elegibles para terapia de resincronización cardiaca? Análisis del estudio RAIC (Registro Andaluz de Insuficiencia Cardiaca)

Revista Espanola de Cardiologia

Volumn 60, Issue 1, 2007, Pages 38-44

  García Pinilla, José M ^a   Jiménez Navarro, Manuel F ^a   Anguita Sánchez, Manuel ^b   Martínez Martínez, Ángel ^c   Torres Calvo, Francisco ^d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Epidemiology; Heart failure; Resynchronization therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; PUBLIC HOSPITAL; QRS COMPLEX; REGISTER; SHORT COURSE THERAPY; SPAIN; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FORWARD HEART FAILURE; HEART PACING; HOSPITALIZATION; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; SEX DIFFERENCE; STANDARD; STATISTICAL MODEL; STATISTICS;

AGED; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; SPAIN;

EID: 33847621255     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13097924     Document Type: Article

References (24)

1. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologic de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol. 1999;33:734-42.
2. Escobar C, Hernández-Madrid A, Blanco B, Escudero J, Marín I, Rondón J, et al. Resincronización cardiaca. Impacto socioeconómico sanitario. Relación coste-beneficio. Rev Esp Cardiol. 2004; 57 Supl 2:192.
3. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med. 2004; 141:381-90.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352: 1539-49.
5. Fernández-Lozano I, Brugada-Terradellas J, Belaza J. Resincronización en España. Implantes por habitante: datos comparativos. Rev Esp Cardiol. 2005;5 Supl B:12-7.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
7. Cleland JG, Coletta AP, Lammiman M, Witte KK, Loh H, Nasir M, et al. Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. Eur J Heart Fail. 2005;7: 1070-5.
8. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416.
9. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26: 1115-40.
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult, summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation. 2005;112: 1825-52.
11. McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B, et al. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J. 2006;27:323-9.
12. Willerson JT, Kereiakes DJ. Cardiac resynchronization therapy: helpful now in selected patients with CHF. Circulation. 2004; 109:308-9.
13. Shen AY, Wang X, Doris J, Moore N. Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. Am J Cardiol. 2004;94: 673-6.
14. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J. 2000;21:1246-50.
15. Werling C, Weisse U, Siemon G, Kiessling AH, Rameken M, Schwacke H, et al. Biventricular pacing in patients with ICD: how many patients are possible candidates? Thorac Cardiovasc Surg. 2002;50:67-70.
16. Grimm W, Sharkova J, Funck R, Maisch B. How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy? Pacing Clin Electrophysiol. 2003;26: 155-7.
17. Pedone C, Grigioni F, Boriani G, Lofiego C, Vassallo PL, Potena L, et al. Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation. Am J Cardiol. 2004;93:371-3.
18. Martínez-Ferrer J, Alonso A, Bello C, Rekondo J, Gil P, Sanz M. Evaluación económica de la estimulación biventricular como tratamiento de los pacientes con insuficiencia cardiaca refractaria. Rev Esp Cardiol. 2003;56 Supl 2:52.
19. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-63.
20. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23:1780-7.
21. Garrigue S, Bordachar P, Reuter S, Jais P, Kobeissi A, Gaggini G, et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart. 2002;87: 529-34.
22. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-94.
23. Curtis AB, Abraham WT, Chen PS, Ellenbogen KA, Epstein AE, Friedman PA, et al. Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California. J Am Coll Cardiol. 2004;44:1550-6.
24. Macías-Gallego A, Ruiz-Granell R. Terapia de resincronización cardiaca: el punto de vista económico. Rev Esp Cardiol. 2005;5 Supl B:18-23.